335066248	335066248	CD	B-NP	O
|	|	NN	I-NP	O
VEHH	VEHH	NN	I-NP	O
|	|	NN	I-NP	O
03031085	03031085	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
3875862	3875862	CD	B-NP	O
|	|	CC	I-NP	O
9/21/2003	9/21/2003	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Pancreatitis	Pancreatitis	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/21/2003	9/21/2003	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
8/14/2003	8/14/2003	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
EMILE	EMILE	NNP	B-NP	O
,	,	,	O	O
DARON	DARON	NNP	B-NP	O
846-29-54-0	846-29-54-0	CD	I-NP	O
Ert	Ert	NNP	I-NP	O
Deownside	Deownside	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/18/03	11/18/03	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SALEHI	SALEHI	NNP	B-NP	O
,	,	,	O	O
ALVIN	ALVIN	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
81	81	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
AMITRIPTYLINE	AMITRIPTYLINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
30	30	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QHS	QHS	NNP	I-NP	I-protein
PREMARIN	PREMARIN	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
CONJUGATED	CONJUGATED	NNP	I-NP	I-protein
ESTROGENS	ESTROGENS	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
0.625	0.625	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	I-protein
FLEXERIL	FLEXERIL	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
CYCLOBENZAPRINE	CYCLOBENZAPRINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
1/24/03	1/24/03	CD	B-NP	O
by	by	IN	B-PP	O
NICKLESS	NICKLESS	NN	B-NP	O
,	,	,	O	O
JAMES	JAMES	NN	B-NP	B-protein
,	,	,	O	O
M.D.	M.D.	NN	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
FLEXERIL	FLEXERIL	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
10	10	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
84391404	84391404	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
DEFINITE	DEFINITE	NNP	I-NP	I-protein
ALLERGY	ALLERGY	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-VP	O
MUSCLE	MUSCLE	VB	I-VP	O
RELAXANTS	RELAXANTS	NNS	B-NP	O
,	,	,	O	O
SKELETAL	SKELETAL	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
meds	med	NNS	I-NP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/18/03	11/18/03	CD	B-NP	O
by	by	IN	B-PP	O
HOKKANEN	HOKKANEN	NNP	B-NP	O
,	,	,	O	O
WALTER	WALTER	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
3/7	3/7	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
AMLODIPINE	AMLODIPINE	NN	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

TOPROL	TOPROL	NN	B-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SUST	SUST	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

100	100	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Number	Number	NN	B-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
IRBESARTAN	IRBESARTAN	NN	I-NP	O
300	300	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/18/03	11/18/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POSSIBLE	POSSIBLE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
SULFA	SULFA	NN	B-NP	O
Reason	Reason	NN	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
LIPITOR	LIPITOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/18/03	11/18/03	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
SERIOUS	SERIOUS	NNS	B-NP	O
INTERACTION	INTERACTION	NN	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	I-NP	O
Adv.	Adv.	NN	I-NP	B-protein
as	as	IN	B-PP	O
tol	tol	NN	B-NP	O
.	.	.	O	O

/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Very	Very	NN	I-NP	B-protein
low	low	JJ	I-NP	I-protein
fat	fat	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
20gms/day	20gms/day	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Bouy	Bouy	NNP	I-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
,	,	,	O	O
U	U	NNP	B-NP	O
Daylis	Daylis	NNP	I-NP	O
Ont	Ont	NNP	I-NP	O
,	,	,	O	O
12	12	CD	B-NP	O
:	:	:	O	O
50	50	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
ask	ask	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Master	Master	NNP	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
referral	referral	NN	I-NP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
appointment	appointment	NN	I-NP	O
8/24/03	8/24/03	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Blaine	Blaine	NNP	I-NP	O
Wehrley	Wehrley	NNP	I-NP	O
,	,	,	O	O
11	11	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
AM	AM	VBP	B-VP	O
6/17/03	6/17/03	CD	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
MRI/A	MRI/A	NN	B-NP	B-protein
of	of	IN	B-PP	O
abdomen	abdoman	NNS	B-NP	O
,	,	,	O	O
SHS	SHS	NNP	B-NP	O
Re	Re	NNP	I-NP	O
Na	Na	NNP	I-NP	O
,	,	,	O	O
New	New	NNP	B-NP	O
Hampshire	Hampshire	NNP	I-NP	O
59460	59460	CD	I-NP	O
,	,	,	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
20	20	CD	B-NP	O
AM	AM	NN	I-NP	O
,	,	,	O	O
please	please	NN	B-NP	O
arrive	arrive	VBP	B-VP	O
30	30	CD	B-NP	O
min	min	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
appt	appt	VB	I-VP	O
and	and	CC	O	O
have	have	VBP	B-VP	O
only	only	RB	B-NP	O
clear	clear	JJ	I-NP	O
liquids	liquid	NNS	I-NP	O
that	that	WDT	B-NP	O
morning	morning	NN	B-NP	O
8/16/03	8/16/03	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Amoxicillin	Amoxicillin	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
,	,	,	O	O
Ciprofloxacin	Ciprofloxacin	NNP	B-NP	O
,	,	,	O	O
Orphenadrine	Orphenadrine	NNP	B-NP	O
citrate	citrate	NN	I-NP	O
,	,	,	O	O
Angiotensin	Angiotensin	NNP	B-NP	O
converting	convert	VBG	B-VP	O
enzyme	enzyme	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Pancreatitis	Pancreatitis	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pancreatitis	Pancreatitis	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
?	?	.	O	O

CARDIOMYOPATHY	CARDIOMYOPATHY	NN	B-NP	O
EF	EF	NN	I-NP	O
=	=	SYM	B-VP	O
39	39	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
SEVERE	SEVERE	NNP	B-NP	O
HYPERCHOL/HYPER	HYPERCHOL/HYPER	NNP	I-NP	O
TG	TG	NNP	I-NP	O
POORLY	POORLY	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
DM	DM	NNP	I-NP	O
S/P	S/P	NNP	I-NP	O
CHOLE/APPY/TAH	CHOLE/APPY/TAH	NNP	I-NP	O
DIFFUSE	DIFFUSE	NNP	I-NP	O
ABDOMINAL	ABDOMINAL	NNP	I-NP	O
PAIN	PAIN	NNP	I-NP	O
ALLG	ALLG	NNP	I-NP	O
:	:	:	O	O
SULFA/AMOXICILLIN	SULFA/AMOXICILLIN	NNP	B-NP	O
OPERATIONS	OPERATIONS	NNPS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNPS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NN	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
with	with	IN	B-PP	O
known	known	JJ	B-NP	O
CAD	CAD	NN	I-NP	O
,	,	,	O	O
atherosclerotic	atherosclerotic	JJ	B-NP	O
peripheral	peripheral	JJ	I-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
type	type	NN	B-NP	O
2	2	CD	I-NP	O
diabetes	diabete	NNS	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
describes	describe	VBZ	B-VP	O
a	a	DT	B-NP	O
sudden	sudden	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
8/10	8/10	CD	B-NP	O
stabbing	stab	VBG	B-VP	O
back	back	RB	B-ADVP	O
pain	pain	NN	B-NP	O
4	4	CD	B-NP	O
days	day	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
without	without	IN	B-PP	O
a	a	DT	B-NP	O
clear	clear	JJ	I-NP	O
precipitant	precipitant	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
non	non	JJ	B-NP	O
raditating	raditating	NN	I-NP	O
and	and	CC	O	O
partially	partially	RB	B-VP	O
releived	releive	VBN	I-VP	O
with	with	IN	B-PP	O
analgesics.She	analgesics.She	NN	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
bowel	bowel	NN	I-NP	O
or	or	CC	I-NP	O
bladder	bladder	NN	I-NP	O
incontinence	incontinence	NN	I-NP	O
or	or	CC	I-NP	O
saddle	saddle	NN	I-NP	O
anesthes	anesthe	NNS	I-NP	O
ia	ia	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
denied	deny	VBD	B-VP	O
any	any	DT	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
chills	chill	NNS	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diarrhea	diarrhea	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
does	do	VBZ	B-VP	O
however	however	RB	B-ADJP	O
complain	complain	JJ	I-ADJP	O
of	of	IN	B-PP	O
some	some	DT	B-NP	O
urinary	urinary	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
on	on	IN	B-PP	O
lasix	lasix	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
with	with	IN	B-PP	O
out	out	RP	B-PRT	O
any	any	DT	B-NP	O
dysuria	dysuria	NN	I-NP	O
or	or	CC	I-NP	O
urgency	urgency	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
month	month	NN	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
increasing	increase	VBG	I-VP	O
had	have	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
however	however	RB	B-ADVP	O
she	she	PRP	B-NP	O
denies	deny	VBZ	B-VP	O
any	any	DT	B-NP	O
orthopnea	orthopnea	NN	I-NP	O
or	or	CC	I-NP	O
PND	PND	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
long	long	RB	I-VP	O
standing	stand	VBG	I-VP	O
pedal	pedal	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
increasing	increase	VBG	I-VP	O
abdominal	abdominal	JJ	B-NP	O
distension	distension	NN	I-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
month	month	NN	I-NP	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
noticed	notice	VBN	I-VP	O
any	any	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
CAD	CAD	NN	B-NP	O
and	and	CC	O	O
her	her	PRP$	B-NP	O
angina	angina	NN	I-NP	O
equivalent	equivalent	NN	I-NP	O
is	be	VBZ	B-VP	O
jaw	jaw	NN	B-NP	O
pain.However	pain.However	RB	B-ADVP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	O
6	6	CD	I-NP	O
months	month	NNS	I-NP	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
intermittent	intermittent	JJ	B-NP	O
left	left	JJ	I-NP	O
sided	sided	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
radiates	radiate	VBZ	B-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
aortic	aortic	JJ	I-NP	O
dissection	dissection	NN	I-NP	O
,	,	,	O	O
MI	MI	NN	B-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
negative	negative	JJ	I-NP	O
D-Dimer	D-Dimer	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-NP	O
lipase	lipase	NN	I-NP	O
levels	level	NNS	I-NP	O
have	have	VBP	B-VP	O
been	be	VBN	I-VP	O
elevated	elevate	VBN	I-VP	O
with	with	IN	B-PP	O
norm	norm	NN	B-NP	O
al	al	JJ	I-NP	O
LFTs	LFT	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
diagnosis	diagnosis	NN	I-NP	O
of	of	IN	B-PP	O
pancreatitis	pancreatitis	NN	B-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

GI	GI	NN	B-NP	O
-	-	HYPH	I-NP	O
S/P	S/P	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
.	.	.	O	O

Her	Her	PRP$	B-NP	B-protein
lipase	lipase	NN	I-NP	I-protein
was	be	VBD	B-VP	O
mildly	mildly	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
200	200	CD	B-NP	O
,	,	,	O	O
fell	fall	VBD	B-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
with	with	IN	B-PP	O
NPO	NPO	NN	B-NP	B-protein
and	and	CC	I-NP	O
IVF	IVF	NN	I-NP	B-protein
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
MRA	MRA	NN	B-NP	B-protein
read	read	VBD	B-VP	O
with	with	IN	B-PP	O
radiology	radiology	NN	B-NP	B-protein
4/4	4/4	CD	I-NP	I-protein
shows	show	VBZ	B-VP	O
diffuse	diffuse	JJ	B-NP	O
atherosclerotic	atherosclerotic	JJ	I-NP	O
disease	disease	NN	I-NP	O
including	include	VBG	B-PP	O
stenosis	stenosis	NN	B-NP	O
of	of	IN	B-PP	O
celiac	celiac	JJ	B-NP	O
artery	artery	NN	I-NP	O
,	,	,	O	O
vascular	vascular	JJ	B-NP	O
surgery	surgery	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
for	for	IN	B-PP	O
concer	concer	NN	B-NP	O
about	about	IN	B-PP	O
mesenteric	mesenteric	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

They	They	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
think	think	VB	I-VP	O
she	she	PRP	B-NP	O
is	be	VBZ	B-VP	O
having	have	VBG	I-VP	O
symptoms	symptom	NNS	B-NP	O
of	of	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
,	,	,	O	O
would	would	MD	B-VP	O
like	like	VB	I-VP	O
abdominal	abdominal	JJ	B-NP	O
MRA	MRA	NN	I-NP	O
to	to	TO	B-VP	O
further	further	RB	I-VP	O
assess	assess	VB	I-VP	O
abdominal	abdominal	JJ	B-NP	O
vasculature	vasculature	NN	I-NP	O
.	.	.	O	O

Triglycerides	Triglyceride	NNS	B-NP	O
very	very	RB	B-ADJP	O
high	high	JJ	I-ADJP	O
,	,	,	O	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
cause	cause	NN	B-NP	O
of	of	IN	B-PP	O
her	her	PRP$	B-NP	O
pancreatitis	pancreatitis	NN	I-NP	O
,	,	,	O	O
starting	start	VBG	B-VP	O
gemfibrozil	gemfibrozil	NN	B-NP	O
.	.	.	O	O

LDL	LDL	NN	B-NP	B-protein
was	be	VBD	B-VP	O
151	151	CD	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardivascular	Cardivascular	JJ	B-NP	O
-	-	HYPH	I-NP	O
Ischemia-On	Ischemia-On	NN	I-NP	O
a	a	DT	B-NP	O
beta	beta	NN	I-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
ARB	ARB	NN	B-NP	B-protein
,	,	,	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
has	have	VBZ	B-VP	O
6	6	CD	B-NP	O
month	month	NN	I-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Adenosine	Adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Started	Started	JJ	B-NP	O
gemfibrozil	gemfibrozil	NN	I-NP	O
.	.	.	O	O

Pump-We	Pump-We	PRP	B-NP	O
changed	change	VBD	B-VP	O
atenolol	atenolol	NN	B-NP	O
to	to	TO	B-PP	O
toprol	toprol	NN	B-NP	O
XL	XL	NN	I-NP	O
and	and	CC	I-NP	O
amlodipine	amlodipine	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Endocrine	Endocrine	JJ	B-NP	O
-	-	HYPH	I-NP	O
Has	Ha	NNPS	I-NP	B-protein
had	have	VBD	B-VP	O
poor	poor	JJ	B-NP	O
glucose	glucose	NN	I-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

HbA1c	HbA1c	NN	B-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
continued	continue	VBD	B-VP	O
NPH	NPH	NN	B-NP	O
qhs	qh	NNS	I-NP	O
and	and	CC	O	O
started	start	VBD	B-VP	O
AM	AM	NNP	B-NP	O
NPH	NPH	NN	I-NP	O
as	as	RB	B-ADVP	O
well	well	RB	I-ADVP	O
.	.	.	O	O

4.Renal-Chronic	4.Renal-Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
Cr	Cr	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
-	-	HYPH	I-NP	O
Patient	Patient	NN	I-NP	O
c/o	c/o	NN	I-NP	O
urinary	urinary	JJ	I-NP	O
frequency	frequency	NN	I-NP	O
.	.	.	O	O

U/A	U/A	NN	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

6.Psych-On	6.Psych-On	JJ	B-NP	O
amitryptilline	amitryptilline	NN	I-NP	O
and	and	CC	I-NP	O
fluoxetine	fluoxetine	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
take	take	VB	B-VP	O
all	all	DT	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
described	describe	VBN	B-VP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
follow	follow	VB	I-VP	O
a	a	DT	B-NP	O
low	low	JJ	I-NP	O
fat	fat	NN	I-NP	O
and	and	CC	O	O
low	low	JJ	B-NP	O
carbohydrate	carbohydrate	NN	I-NP	O
diet	diet	NN	I-NP	O
to	to	TO	B-VP	O
control	control	VB	I-VP	O
your	your	PRP$	B-NP	O
cholesterol	cholesterol	NN	I-NP	O
and	and	CC	I-NP	O
diabetes	diabetes	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	B-protein
take	take	VBP	B-VP	O
insulin	insulin	NN	B-NP	B-protein
in	in	IN	B-PP	O
the	the	DT	B-NP	O
morning	morning	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
the	the	DT	B-NP	O
night	night	NN	I-NP	O
,	,	,	O	O
check	check	VB	B-VP	O
your	your	PRP$	B-NP	O
fingersticks	fingerstick	NNS	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
and	and	CC	O	O
record	record	VB	B-VP	O
them	them	PRP	B-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
see	see	VB	I-VP	O
Dr.	Dr.	NNP	B-NP	O
Colleen	Colleen	NNP	I-NP	O
on	on	IN	B-PP	O
5/14	5/14	CD	B-NP	O
and	and	CC	O	O
ask	ask	VB	B-VP	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
insulin	insulin	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-INTJ	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
MRI	MRI	NN	I-NP	O
appointment	appointment	NN	I-NP	O
8/21	8/21	CD	I-NP	O
and	and	CC	O	O
see	see	VB	B-VP	O
Dr.	Dr.	NNP	B-NP	O
Cicerchia	Cicerchia	NNP	I-NP	O
6/23	6/23	CD	I-NP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
emergency	emergency	NN	I-NP	O
room	room	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
severe	severe	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
abdominal	abdominal	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
HUNEYCUTT	HUNEYCUTT	NN	B-NP	O
,	,	,	O	O
IRVING	IRVING	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
MY65	MY65	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/18/03	11/18/03	CD	I-NP	O
@	@	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
03	03	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

